DK1141358T3 - Stabilt transfekterede celler til identificering af forbindelser, der påvirker stabiliteten af mRNA - Google Patents

Stabilt transfekterede celler til identificering af forbindelser, der påvirker stabiliteten af mRNA

Info

Publication number
DK1141358T3
DK1141358T3 DK99962013T DK99962013T DK1141358T3 DK 1141358 T3 DK1141358 T3 DK 1141358T3 DK 99962013 T DK99962013 T DK 99962013T DK 99962013 T DK99962013 T DK 99962013T DK 1141358 T3 DK1141358 T3 DK 1141358T3
Authority
DK
Denmark
Prior art keywords
mrna
stability
transfected cells
stably transfected
identify compounds
Prior art date
Application number
DK99962013T
Other languages
English (en)
Inventor
Tania Kastelic
Dominique Cheneval
Original Assignee
Novation Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novation Pharmaceuticals Inc filed Critical Novation Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1141358T3 publication Critical patent/DK1141358T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99962013T 1998-12-24 1999-12-23 Stabilt transfekterede celler til identificering af forbindelser, der påvirker stabiliteten af mRNA DK1141358T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828709.7A GB9828709D0 (en) 1998-12-24 1998-12-24 Assay
PCT/CA1999/001235 WO2000039314A1 (en) 1998-12-24 1999-12-23 ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF mRNA

Publications (1)

Publication Number Publication Date
DK1141358T3 true DK1141358T3 (da) 2008-03-31

Family

ID=10845082

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99962013T DK1141358T3 (da) 1998-12-24 1999-12-23 Stabilt transfekterede celler til identificering af forbindelser, der påvirker stabiliteten af mRNA

Country Status (12)

Country Link
US (1) US20150176088A1 (da)
EP (1) EP1141358B1 (da)
JP (1) JP2002541767A (da)
AT (1) ATE380249T1 (da)
AU (1) AU776604C (da)
CA (1) CA2356621C (da)
DE (1) DE69937689T2 (da)
DK (1) DK1141358T3 (da)
ES (1) ES2299273T3 (da)
GB (1) GB9828709D0 (da)
PT (1) PT1141358E (da)
WO (1) WO2000039314A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140069A1 (en) 1998-12-24 2001-10-10 Novation Pharmaceuticals Inc. COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
US7598079B2 (en) * 1998-12-24 2009-10-06 Novation Pharmaceuticals, Inc. Assay for identifying compounds which affect stability of mRNA
EP1373528B1 (en) * 2001-03-09 2008-08-13 Gene Stream Pty Ltd. Novel expression vectors
US7799827B2 (en) 2002-03-08 2010-09-21 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
US7915306B2 (en) 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
US7399583B2 (en) 2002-04-17 2008-07-15 Novartis Ag Method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein
US20040146987A1 (en) * 2002-09-16 2004-07-29 Promega Corporation Rapidly degraded reporter fusion proteins
US9068234B2 (en) 2003-01-21 2015-06-30 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating gene expression
EP1604011A4 (en) 2003-01-21 2009-12-09 Ptc Therapeutics Inc METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE THE EXPRESSION OF DEPENDENT GENES FROM A NON-TRANSLATED REGION, AND METHODS OF USING SAME
US8426194B2 (en) 2003-01-21 2013-04-23 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating VEGF expression
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
UA92317C2 (ru) 2004-03-15 2010-10-25 Пи-Ти-Си ТЕРАПЬЮТИКС, ИНК. Производные карболина, пригодные для ингибирования развития кровеносных сосудов
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
US8283115B1 (en) 2007-06-20 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
US8283116B1 (en) 2007-06-22 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
KR101573026B1 (ko) 2007-07-25 2015-11-30 에자이 알앤드디 매니지먼트 가부시키가이샤 암 치료에서 이용하기 위한 멀티키나아제 억제제
US11576892B2 (en) 2015-08-18 2023-02-14 Novation Pharmaceuticals Inc. Benzopyran derivatives and uses thereof
DK3436469T3 (da) * 2016-03-31 2022-03-21 Berkeley Lights Inc Nukleinsyrestabiliseringsreagens, kits og fremgangsmåder til anvendelse deraf
CN116426610B (zh) * 2023-06-08 2024-01-05 启辰生生物科技(珠海)有限公司 一种LC-MS法准确定量mRNA加帽效率的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174666B1 (en) * 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
CA2191583C (en) * 1994-06-07 2007-03-27 Engin Ozkaynak Methods and compositions for modulating morphogenic protein expression
US5731343A (en) * 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
US6627398B1 (en) * 1998-05-26 2003-09-30 University Of Medicine And Dentistry Of New Jersey System for reproducing and modulating stability and turnover of RNA molecules

Also Published As

Publication number Publication date
EP1141358B1 (en) 2007-12-05
CA2356621C (en) 2013-03-26
EP1141358A1 (en) 2001-10-10
ATE380249T1 (de) 2007-12-15
AU1852200A (en) 2000-07-31
US20150176088A1 (en) 2015-06-25
PT1141358E (pt) 2008-03-17
CA2356621A1 (en) 2000-07-06
ES2299273T3 (es) 2008-05-16
AU776604C (en) 2005-05-12
AU776604B2 (en) 2004-09-16
JP2002541767A (ja) 2002-12-10
DE69937689T2 (de) 2008-08-28
WO2000039314A1 (en) 2000-07-06
DE69937689D1 (de) 2008-01-17
GB9828709D0 (en) 1999-02-17

Similar Documents

Publication Publication Date Title
DK1141358T3 (da) Stabilt transfekterede celler til identificering af forbindelser, der påvirker stabiliteten af mRNA
DE60233049D1 (de) Matrix-anheftungsregionen und verfahren zu deren verwendung
DK1137798T3 (da) Fremgangsmåde til isolering af stamceller
NO20004217L (no) Inhibitorer av fosfolipase A2
DE69822206D1 (de) Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
PT1084103E (pt) Novo derivado do acido 3-aril-2-hidroxipropionico (i)
DK1266018T3 (da) Fremstilling af udskilte proteiner af rekombinante, eukaryotiske celler
DE69941367D1 (de) Multienzym-nachweisverfahren
ATE407213T1 (de) Adenovirale vektoren, die zellstatus-spezifische regulatorische elemente enthalten und methoden für ihre verwendung
DE60140120D1 (de) Toxizitätstypisierung unter verwendung von leberstammzellen
WO2000056762A3 (en) Methods for monitoring multiple gene expression
WO2002029113A3 (en) Methods for monitoring multiple gene expression
DE69929236D1 (de) Bipolare platte für brennstoffzellen
BR0313145A (pt) Sistema de célula eletroquìmica, célula metal-ar e método de operar um sistema de célula eletroquìmica
TR199802503A3 (tr) Endojen gen aktivasyonu için hücrelerin optimizasyonu.
DE69942063D1 (de) Antagonisten von 'hedgehog' und 'patched' zur inhibierung des wachstums und der differenzierung von zellen und geweben, als auch deren verwendungen
DE69734204D1 (de) Lichtproduzierender biosensor
PT942999E (pt) Construcao armadilha de genes para a identificacao e isolamento de genes
DK1348124T3 (da) Identifikation af individuelle celler under kinetiske assays
WO2004022782A3 (en) Compositions and methods for tissue specific or inducible inhibition of gene expression
WO2002000871A3 (de) Verfahren zur einbringung von nukleinsäuren und anderen biologisch aktiven molekülen in der kern höherer eukaryontischer zellen mit hilfe elektrischen stroms
DE60031369D1 (de) Replikation -defektive baculoviren expressionssystem
DE602004015643D1 (de) Tab-system für eine elektrochemische metall-luft-zelle
TR200001070A2 (tr) İzosiyanat içeren bağlayıcılar.
ATE302282T1 (de) Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen